$709.00M
Revenue
$-679.39M
Net Income
68.08%
Gross Margin
-92.04%
Op. Margin
$15.15M
Free Cash Flow
| Breakdown | FY 2026 (Jan 31, 2026) |
|---|---|
| Total Revenue | $709.00M |
| Revenue Growth % | nan% |
| Cost of Revenue | $226.33M |
| Gross Profit | $482.67M |
| Gross Margin % | 68.1% |
| Research & Development | $509.03M |
| Operating Income | $-652.58M |
| Operating Margin % | -92.0% |
| Interest Expense | - |
| Other Income/Expense | $18.78M |
| Income Before Tax | $-668.05M |
| Income Tax Expense | $11.34M |
| Net Income | $-679.39M |
| Net Margin % | -95.8% |
| Basic EPS | -3.18 |
| Diluted EPS | -3.18 |
| Basic Shares Outstanding | 213.9M |
| Diluted Shares Outstanding | 213.9M |
| Breakdown | FY 2026 (Jan 31, 2026) |
|---|---|
| Cash & Cash Equivalents | $432.58M |
| Short-term Investments | $725.60M |
| Accounts Receivable | $158.28M |
| Inventory | $4.90M |
| Other Current Assets | $73.55M |
| Total Current Assets | $1.45B |
| Property Plant & Equipment | $93.88M |
| Goodwill | $61.08M |
| Intangible Assets | $21.40M |
| Other Non-current Assets | $14.07M |
| Total Assets | $1.77B |
| Accounts Payable | $14.44M |
| Deferred Revenue | $532.73M |
| Total Current Liabilities | $681.53M |
| Other Non-current Liabilities | $8.72M |
| Total Liabilities | $1.58B |
| Retained Earnings | $-2.63B |
| Total Stockholders Equity | $194.53M |
| Total Liabilities & Equity | $1.77B |
| Breakdown | FY 2026 (Jan 31, 2026) |
|---|---|
| Net Income | $-679.39M |
| Depreciation & Amortization | $30.10M |
| Stock-based Compensation | $516.19M |
| Deferred Income Tax | $-2.26M |
| Change in Receivables | $-36.82M |
| Change in Inventory | $-529.00K |
| Change in Payables | $11.35M |
| Operating Cash Flow | $38.07M |
| Capital Expenditure | $22.92M |
| Acquisitions | - |
| Purchases of Investments | $805.66M |
| Investing Cash Flow | $-666.87M |
| Stock Repurchased | $565.00K |
| Financing Cash Flow | $895.37M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Oct 31, 2025
Condensed Consolidated Statements of Operations
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $184.17M | - | $512.67M | - |
| Cost of Revenue | $77.53M | - | $173.27M | - |
| Gross Profit | $106.64M | - | $339.40M | - |
| Research & Development | $262.70M | - | $403.44M | - |
| Operating Income | $-446.97M | - | $-538.29M | - |
| Other Income/Expense | $5.41M | - | $9.53M | - |
| Income Tax Expense | $3.07M | - | $8.01M | - |
| Net Income | $-453.07M | $-111.57M | $-622.62M | - |
| Basic EPS | -1.85 | - | -4.07 | - |
| Diluted EPS | -1.85 | - | -4.07 | - |
| Basic Shares Outstanding | $244.66M | - | $153.01M | - |
| Diluted Shares Outstanding | $244.66M | - | $153.01M | - |
Condensed Consolidated Balance Sheets
| Description | Oct 31, 2025 | Jan 31, 2025 |
|---|---|---|
| Cash & Cash Equivalents | $984.65M | $166.01M |
| Short-term Investments | $168.25M | $80.68M |
| Accounts Receivable | $131.53M | $195.10M |
| Inventory | $5.38M | $5.76M |
| Other Current Assets | $63.21M | $37.99M |
| Total Current Assets | $1.40B | $528.40M |
| Property Plant & Equipment | $89.54M | $99.48M |
| Goodwill | $61.08M | $61.08M |
| Intangible Assets | $23.89M | $37.24M |
| Other Non-current Assets | $16.67M | $18.92M |
| Total Assets | $1.72B | $858.51M |
| Accounts Payable | $16.43M | $2.65M |
| Deferred Revenue | $471.45M | $430.16M |
| Total Current Liabilities | $602.99M | $526.71M |
| Other Non-current Liabilities | $7.74M | $4.81M |
| Total Liabilities | $1.56B | $1.34B |
| Retained Earnings | $-2.57B | $-1.95B |
| Total Stockholders Equity | $151.03M | $-485.59M |
| Total Liabilities & Equity | $1.72B | $858.51M |
Condensed Consolidated Statements of Cash Flows
| Description | Oct 31, 2025 | Oct 31, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-453.07M | $-111.57M | $-622.62M | - |
| Stock-based Compensation | - | - | $428.11M | - |
| Deferred Income Tax | - | - | - | - |
| Change in Receivables | - | - | $-63.57M | - |
| Change in Inventory | - | - | $-149.00K | - |
| Change in Payables | - | - | $13.36M | - |
| Operating Cash Flow | - | - | $19.95M | - |
| Capital Expenditure | - | - | $9.56M | - |
| Acquisitions | - | - | - | - |
| Purchases of Investments | - | - | $197.15M | - |
| Investing Cash Flow | - | - | $-98.64M | - |
| Financing Cash Flow | - | - | $897.33M | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.